Overexpression of IL-22 by gene targeting or delivery through adenovirus expressing IL-22 has previously been shown to reduce liver fibrosis and accelerate fibrosis resolution during recovery in the carbon tetrachloride (CCl4) model19,24. This evidence concerns the gene IL22 and fibrosis.